A federal judge has conditionally certified a nationwide class action for medical monitoring on behalf of consumers who took the fen-phen diet drug combination for at least 30 days and now fear an increased risk of heart valve disease.

In a 41-page opinion handed down late yesterday, Senior U.S. District Judge Louis C. Bechtle rejected the argument that such a massive class action would be impossible to manage due to factors that make each individual plaintiff’s claim unique or the need to apply the laws of all 50 states.

This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.

To view this content, please continue to their sites.

Not a Lexis Subscriber?
Subscribe Now

Not a Bloomberg Law Subscriber?
Subscribe Now

Why am I seeing this?

LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.

For questions call 1-877-256-2472 or contact us at [email protected]